Renodon-Cornière Axelle, Jensen Lars H, Nitiss John L, Jensen Peter B, Sehested Maxwell
Department of Pathology, Laboratory and Finsen Centers, Rigshospitalet 5444, DK-2100 Copenhagen, Denmark.
Biochemistry. 2002 Nov 12;41(45):13395-402. doi: 10.1021/bi0263614.
DNA topoisomerase II is an ATP-operated clamp that effects topological changes by capturing a double-stranded DNA segment and transporting it through another duplex. Surface plasmon resonance (SPR) was used to characterize interactions of human topoisomerase II alpha with different topological forms of DNA. Using a linear fragment of pUC18 DNA, the equilibrium binding constant of topoisomerase II alpha was determined to be 0.16 nM. The affinity was not affected by the absence of ATP or the presence of the bisdioxopiperazine catalytic inhibitor ICRF-187. Besides, similar affinities were found for several bisdioxopiperazine-resistant mutant enzymes. These results suggest that the mechanism of topoisomerase II alpha inhibition by ICRF-187 and its resistance does not directly involve the interaction of DNA with the enzyme. SPR was also adapted to measure levels of the closed clamp form of topoisomerase II present on DNA. As expected, a stable closed clamp form of the enzyme was detectable on circular DNA but not on linear DNA. Detection of the closed clamp required the presence of ATP and a bisdioxopiperazine, or a non-hydrolyzable analogue of ATP. In the presence of ATP and ICRF-187, several bisdioxopiperazine-resistant mutant enzymes failed to form detectable levels of stable closed clamp. Interestingly, a mutant of human topoisomerase II alpha with an altered active site tyrosine showed lower levels of closed clamp formation. In conclusion, SPR is able to (1) determine the kinetics of topoisomerase II with its DNA substrate and (2) quantify the enzyme's closed clamp formation under varying circumstances.
DNA拓扑异构酶II是一种由ATP驱动的夹子,通过捕获双链DNA片段并使其穿过另一个双链体来实现拓扑变化。表面等离子体共振(SPR)被用于表征人拓扑异构酶IIα与不同拓扑形式DNA的相互作用。使用pUC18 DNA的线性片段,测定拓扑异构酶IIα的平衡结合常数为0.16 nM。该亲和力不受ATP缺失或双二氧哌嗪催化抑制剂ICRF-187存在的影响。此外,几种对双二氧哌嗪耐药的突变酶也表现出相似的亲和力。这些结果表明,ICRF-187对拓扑异构酶IIα的抑制机制及其耐药性并不直接涉及DNA与该酶的相互作用。SPR还被用于测量DNA上存在的拓扑异构酶II的闭合夹子形式的水平。正如预期的那样,在环状DNA上可检测到该酶的稳定闭合夹子形式,而在线性DNA上则检测不到。检测闭合夹子需要ATP和双二氧哌嗪或ATP的非水解类似物的存在。在ATP和ICRF-187存在的情况下,几种对双二氧哌嗪耐药的突变酶未能形成可检测水平的稳定闭合夹子。有趣的是,人拓扑异构酶IIα的一个活性位点酪氨酸发生改变的突变体显示出较低水平的闭合夹子形成。总之,SPR能够(1)确定拓扑异构酶II与其DNA底物的动力学,以及(2)在不同情况下量化该酶的闭合夹子形成。